India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India-focused Independent Equity Research Analyst

Experienced (7 years +) in Sector-Specific Deep Dives and Comprehensive Company Research.

With a sharp focus on the Indian market, I specialize in providing in-depth analysis and insights to investors. Whether it's dissecting various sectors to identify emerging trends or conducting thorough fundamental research on individual companies, I'm dedicated to uncovering valuable opportunities and delivering actionable intelligence.

Passionate about navigating the nuances of the Indian equity landscape, I thrive on deciphering complex market dynamics and distilling them into clear, concise insights. 

While covering a sector or company-specific research, I cover the following :
1. Brief about company/sector
2.  Overall Industry landscape - History, Present and Future trends
3. Thesis and Anti-Thesis
4. Valuations
5. Financial & Forensic Analysis
6. Management Review
7. Key Monitorable Events
8. Guidance and Future Way Ahead

India Equity Analyst - Fundamental & Thematic

Sai Parenterals: From Injectables Niche to a Global Formulations Platform

Fermenta Biotech: Specialty Nutrition and Green Chemistry Play

Genus Power: GIC Exit, HNI Buying and the ₹25,173 Crore Order Book

Sudeep Pharma: Building From Specialty Ingredients to Battery Materials

Gufic Biosciences: Indore Plant Ramp-Up Sets the Stage for FY27 Recovery

Swiggy: Discipline Over Discounting Becomes the Real Story

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

Sudarshan Chemical Industries / Equity Bottom-Up

<ul>
<li>Sudarshan Chemical Industries, a global pigment manufacturer, reported Q4 FY26 consolidated revenue of INR 2,790 crore, EBITDA of INR 247 crore and reduced net debt to INR 755 crore.</li>
<li>The acquired business exceeded EBITDA guidance, inventory reduction improved cash flows, and execution remains on track to achieve €35 million FY27 EBITDA and €90–100 million medium-term target.</li>
<li>The turnaround is gaining momentum. Sustained EBITDA growth, synergy realization, working capital optimization, and continued deleveraging are expected to drive earnings growth and support further valuation rerating.</li>
</ul>


Sudarshan Chemical Industries, a global pigment manufacturer, reported Q4 FY26 consolidated revenue of INR 2,790 crore, EBITDA of INR 247 crore and reduced net debt to INR 755 crore.
The acquired business exceeded EBITDA guidance, inventory reduction improved cash flows, and execution remains on track to achieve €35 million FY27 EBITDA and €90–100 million medium-term target.
The turnaround is gaining momentum. Sustained EBITDA growth, synergy realization, working capital optimization, and continued deleveraging are expected to drive earnings growth and support further valuation rerating.


Sudarshan Chemical: Heubach Acquisition Starts Delivering Results